CT VScore+ vs EchoNext

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Canon Medical Informatics
VS
by Pathway Labs

AI Verdict

While both tools operate within Cardiology AI and are FDA-cleared, they target different diagnostic modalities and disease aspects. CT VScore+ focuses on automated cardiac calcium scoring from CT images for coronary risk assessment, whereas EchoNext analyzes standard ECGs to detect hidden structural heart disease like heart failure and valve disease. Therefore, the choice between them depends on whether the clinical need is for CT-based calcium scoring or ECG-based structural heart disease detection.

Choose CT VScore+ if…

Choose CT VScore+ if your cardiology or radiology practice frequently performs ECG-gated, non-contrast cardiac CT scans and needs to streamline the cardiac calcium scoring workflow. This tool is ideal for automating Agatston and volume score generation, reducing manual data entry, and enhancing efficiency in coronary risk assessment, especially with increasing imaging volumes.

View CT VScore+ →

Choose EchoNext if…

Choose EchoNext if your practice aims to non-invasively screen a broad patient population for hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension, using standard 12-lead ECGs. This AI tool is particularly well-suited for early detection in primary care or hospital settings to identify high-risk patients who may require further cardiac ultrasound evaluation.

View EchoNext →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CT VScore+ EchoNext
Pricing Contact for pricing Starts at $600/month
Deployment On-premise Available through the OpenEvidence clinical decision support platform.
BAA Available Unknown Yes AI-estimated
FDA Status 1 AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CT VScore+

CT VScore+ integrates with the Vitrea platform and automates cardiac calcium scoring, reducing manual data entry and streamlining workflow for technologists and physicians. EchoNext analyzes standard ECGs, which are routine and inexpensive, but its deployment is through the OpenEvidence platform, and specific user experience details are less elaborated.

Clinical Value

EchoNext

EchoNext demonstrates high accuracy in detecting a range of structural heart problems from ECGs, outperforming cardiologists in studies, and has been credited with guiding care that led to a heart transplant. CT VScore+ provides automated Agatston and volume scores for coronary risk assessment with high clinical reliability and agreement to expert interpretation, but its impact on patient outcomes is not as explicitly highlighted in the provided information.

Pricing & Value

EchoNext

EchoNext offers transparent tiered pricing starting at $600/month, including details on implementation fees and annual discounts, making its cost structure clear. CT VScore+ requires contacting for pricing, which makes a direct comparison of value difficult due to a lack of transparency.

Enterprise Readiness

CT VScore+

CT VScore+ is from Canon Medical Informatics, an established company, and is deployed on-premise, integrating with the Vitrea platform, which suggests strong compatibility with existing hospital IT infrastructures. EchoNext is available through the OpenEvidence platform and is HIPAA compliant with BAA, but its deployment model might be less flexible for some enterprise environments compared to an on-premise solution.

Innovation

EchoNext

EchoNext is highlighted as the world's first FDA-cleared AI detection tool to analyze standard ECGs for hidden structural heart disease, representing a novel approach to early detection. CT VScore+ offers automated cardiac calcium scoring, which is an advancement in efficiency, but the core technology of calcium scoring from CT is more established.

Support & Docs

CT VScore+

Canon Medical Informatics offers comprehensive customer support for CT VScore+, including 24/7 access to staff, professional services consulting, administration training, and an online portal with educational resources and security bulletins. Pathway Labs provides support for EchoNext through API docs, troubleshooting guides, GitHub issues, Discord, and email, which is more geared towards developers and technical users rather than comprehensive clinical enterprise support.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CT VScore+ EchoNext
Tool Name CT VScore+ EchoNext
Company Canon Medical Informatics Pathway Labs
Description AI-powered software application that automates cardiac calcium scoring from ECG-gated, non-contrast cardiac CT images, providing Agatston and volume scores for coronary risk assessment. FDA-cleared AI tool that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Clinical Decision Support & Reference, Lab & Diagnostics
Key Features Automated cardiac calcium scoring, Removes manual data entry from reporting, Generates Agatston and volume calcium scores, Highlights segmented calcium on CT images, Runs on Vitrea platform, Non-invasive evaluation of coronary artery calcified lesions, Utilizes ECG-gated, non-contrast cardiac CT images, Provides calcium percentile comparison to reference data (MESA, Hoff-Kondos) AI-powered ECG analysis, Detection of hidden structural heart disease, Identifies heart failure risk, Screens for valve disease, Detects pulmonary hypertension indicators, Utilizes standard 12-lead ECGs, FDA-cleared technology, Non-invasive diagnostic support

Videos

Demos, reviews, and walkthroughs featuring CT VScore+ and EchoNext.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

CT VScore+ is designed to run on the Vitrea platform and automates cardiac calcium scoring from ECG-gated CT images, removing manual data entry from reporting. EchoNext, on the other hand, analyzes standard ECGs and is available through the OpenEvidence clinical decision support platform, suggesting integration with existing ECG interpretation and clinical decision support workflows.
CT VScore+ provides automated Agatston and volume scores for coronary risk assessment and offers calcium percentile comparison to reference data (MESA, Hoff-Kondos). EchoNext is an FDA-cleared AI tool that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.
CT VScore+ is specifically designed for cardiology and radiology, focusing on non-invasive evaluation of coronary artery calcified lesions using ECG-gated, non-contrast cardiac CT images. EchoNext is applicable across a broader range of specialties including cardiology, family medicine, hospital medicine, and internal medicine, as it screens for hidden structural heart disease using standard 12-lead ECGs.
CT VScore+ automates cardiac calcium scoring and removes manual data entry, suggesting a potentially streamlined workflow once integrated into the Vitrea platform. EchoNext analyzes standard ECGs, which are a familiar diagnostic tool, and is available through a clinical decision support platform, which may facilitate adoption.
CT VScore+ generates Agatston and volume calcium scores and highlights segmented calcium on CT images, which would contribute to a detailed audit trail for coronary risk assessment. EchoNext provides AI-powered ECG analysis for the detection of hidden structural heart disease, which would likely generate reports detailing its findings for clinical documentation.
CT VScore+ automates a previously manual process of cardiac calcium scoring, potentially saving time and increasing efficiency in reporting. EchoNext offers non-invasive diagnostic support for detecting hidden structural heart disease from standard ECGs, which could lead to earlier intervention and improved patient outcomes.
AI Tool Finder
AI-powered search. Results may not be comprehensive.